Heligenics, Inc. — Form D
Heligenics, Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-16. The offering totals $2.4M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-16
- Form: D
- Accession: 0001833506-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $1.2M
- Remaining: $1.2M
- Minimum investment: $2K
- Investors: 39
- Date of first sale: 2020-03-31
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-383332
Issuer
- Name: Heligenics, Inc.
- CIK: 0001833506
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2019
- Address: 10530 DISCOVERY DR, LAS VEGAS, NV, 89135
- Phone: (209) 480-5774
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Lawrence John Loomis | Director | Las Vegas, NV |
| Lawrence John Loomis | Executive Officer | Las Vegas, NV |
| Martin Schiller | Executive Officer | LAS VEGAS, NV |
| Martin R Schiller | Executive Officer | Las Vegas, NV |
Other filings by this issuer (2)
More